5. Discussion and perspective
Authors:
(1) Hui Zong, a joint laboratory for critical assistance in medical artificial intelligence, critical assistance at the Medical Department and Systems Genetics Institutes, Frontiers Science Center for Molecular Networks, Western -China Hospital, Sichuan University, Chengdu, 610041, China and author contributed equally;
(2) Rongong Wu, a joint laboratory for critical assistance in medical artificial intelligence, critical assistance at the Medical Department and Systems Genetics Institutes, Frontiers Science Center in Moleclamic Network, West -China Hospital, Sichuan University, Chengdu, 610041, China and author contributed equally;
(3) Jiaxue Cha, Shanghai Signal Laboratory, Receptor -based Biomedicin Laboratory, Brain Science Cooperation Innovation Center, Life Sciences and Technology, Tongji University, Shanghai, 200092, China;
(4) Erman Wu, a common laboratory for critical assistance in medical artificial intelligence, critical assistance at the medical department and system institutes of genetics, Frontiers science molecular mesh, West -China Hospital, Sichuan University, Chengdu, 610041, China;
(5) Jiakun Li, a common laboratory for critical assistance in medical artificial intelligence, critical assistance in the medical department and the Institutes of Genetics of Systems, Frontiers Science Center Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China and Urology Department, West Hospital 610041, China;
(6) Liang Tao, Shanghai Business School, Shanghai, 201400, China;
(7) Zuofeng Li, Takeda Co. Ltd., Shanghai, 200040, China;
(8) Buzhou Tang, Computer Science Department of the Harbin Institute of Technology, Shenzhen, 518055, China;
(9) Bairong Shen, a joint laboratory for critical assistance in medical artificial intelligence, critical assistance at the Medical Department and Systems Genetics Institutes, Frontiers Science Center for Disease Molecular Network, West -China Hospital, Sichuan University, Chengdu, 610041, China and Author.
